Learn More
Medchemexpress LLC IACS-13909 | 2160546-07-4 | 99.97% | 377.27 | 25 MG

Supplier: Medchemexpress LLC 25MGHY137092
IACS-13909 is a selective, potent, and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. It demonstrates greater selectivity for SHP2 compared to other phosphatases, including SHP1. This compound exhibits antitumor activities and effectively suppresses MAPK pathway signaling in receptor tyrosine kinase (RTK)-dependent cancers.
- Selective, potent, and orally active SHP2 allosteric inhibitor
- Greater selectivity for SHP2 compared to other phosphatases
- Exhibits antitumor activities
- Suppresses MAPK pathway signaling in RTK-dependent cancers
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.